Attruby (acoramidis) is an FDA-approved medication for treating transthyretin-mediated amyloidosis with cardiomyopathy (ATTR-CM). It works by stabilizing the transthyretin protein to prevent harmful amyloid deposits in the heart. It is taken as two oral tablets twice daily. While it is a competitor to tafamidis Show Full Answer

Attruby (acoramidis) is an FDA-approved medication for treating transthyretin-mediated amyloidosis with cardiomyopathy (ATTR-CM). It works by stabilizing the transthyretin protein to prevent harmful amyloid deposits in the heart. It is taken as two oral tablets twice daily. While it is a competitor to tafamidis (Vyndamax/Vyndaqel), individual experiences may vary. Always consult your doctor to determine the best treatment for your condition. For more details, visit: url: https://www.myamyloidosisteam.com/treatments/at...

 This AI-generated response comes from MyAmyloidosisTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Attruby (Acoramidis) for Amyloidosis | MyAmyloidosisTeam

hATTR Amyloidosis Treatments: Comparing Your Options | MyAmyloidosisTeam